Centessa Pharmaceuticals plc - ADR

NASDAQ:CNTA  
12.67
-0.08 (-0.63%)
Earnings Announcements

Centessa Pharmaceuticals Q3 Loss Per Share $0.45

Published: 11/15/2021 12:46 GMT
Centessa Pharmaceuticals plc - ADR (CNTA) - Q3 Loss per Share $0.45.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.53

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.74

More details on our Analysts Page.